Phase II study of 4'epi-doxorubicin.

Ferrazzi, E; Nicoletto, O; Vinante, O; Pagnin, P; Maraglino, G; Ganzina, F; Fiorentino, M V

Ferrazzi, E; Nicoletto, O; Vinante, O; Pagnin, P; Maraglino, G; Ganzina, F; Fiorentino, M V.

Tumori ; 68(5): 431-5, 1982 Oct 31.

Article in En | MEDLINE | ID: mdl-6960591

Subject(s)

Antineoplastic Agents/therapeutic use; Doxorubicin/therapeutic use; Neoplasms/drug therapy; Adult; Aged; Antineoplastic Agents/adverse effects; Breast Neoplasms/drug therapy; Colonic Neoplasms/drug therapy; Doxorubicin/adverse effects; Drug Evaluation; Epirubicin; Female; Heart/drug effects; Humans; Male; Melanoma/drug therapy; Middle Aged; Sarcoma/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Tumori Year: 1982 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links